Form 4: HealthEquity CTO Sells Shares for Tax Obligations

HealthEquity's EVP and Chief Technology Officer, Elimelech Rosner, disposed of 2,074 shares of common stock to cover tax withholding obligations.

Summary

• Elimelech Rosner, EVP, Chief Technology Officer of HealthEquity, Inc. (HQY), reported a disposition of common stock.
• The transaction involved 2,074 shares of common stock.
• The shares were disposed of at a weighted average price of $95.2365 per share, with prices ranging from $95.2358 to $95.2369.
• The disposition was made to satisfy tax withholding obligations.
• Following this transaction, Mr. Rosner beneficially owns 43,668 shares of HealthEquity common stock.
• The transaction was executed on January 9, 2026, and reported on January 13, 2026.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged plan.

Sentiment

Score: 5

Explanation: The transaction is neutral as it represents a routine disposition of shares for tax withholding purposes, often associated with the vesting of equity compensation. The Rule 10b5-1 plan further indicates a pre-planned, non-discretionary event.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on immediate insider information.
• The disposition was for tax withholding, a common and expected event for executives receiving equity compensation.

Negatives

• A reduction in direct beneficial ownership by a key executive, although for tax purposes, slightly decreases their direct stake in the company.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, common across all industries for publicly traded companies. It does not reflect specific industry trends for healthcare or financial services.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but for a routine tax-related purpose, unlikely to have significant impact.
• Employees: No direct impact on employees mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of equity awards, executed under a Rule 10b5-1 plan. Such transactions are common and generally do not indicate a change in management's outlook or confidence in the company. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Sale, Executive Compensation, Elimelech Rosner, Tax Withholding, Rule 10b5-1